Patents Assigned to HBV Theranostica AB
  • Methods and means relating to hepatitis B infection
    Patent number: 8076085
    Abstract: The present inventors have discovered that the presence of antibodies reactive with residues 94-117 of the PreS1 component of the hepatitis B surface antigen (HBsAg) in an individual with HBV infection correlates closely with the effectiveness of interferon (IFN) in treating the individual. Methods and means based on this finding are provided herein.
    Type: Grant
    Filed: October 22, 2004
    Date of Patent: December 13, 2011
    Assignee: HBV Theranostica AB
    Inventors: Ulla Hellstrom, Staffan Sylvan